- AT-587 is a proprietary oral antiviral nucleotide analog being developed for the treatment of HEV.
- Current hepatitis E virus knowledge in Ireland is limited, creating uncertainty in assessing the risk related to the consumption of pork products. Despite the lack of information, the Food Safety Authority of Ireland (FSAI) said the available data supports the hypothesis that the pig meat food chain contributes to the
- World Hepatitis Day is July 28th—see how viral hepatitis impacts millions and what CDC is doing.
- Atea Pharmaceuticals Inc. recently presented preclinical data on two of its compounds, AT-2490 and AT-587, which have shown promising antiviral potential for treating hepatitis E virus infection.
- Phase 1 Study Designed to Evaluate the Safety, Tolerability and Pharmacokinetics of AT-587 in Healthy Volunteers
- Atea begins phase 1 trial of hepatitis E treatment AT-587
- Phase 1 Study Designed to Evaluate the Safety, Tolerability and Pharmacokinetics of AT-587 in Healthy Volunteers AT-587 is a Potential First-in Class…
- AT-587 was 30- to 150-fold more potent in vitro than sofosbuvir and ribavirin; its Phase 1 study will assess safety, tolerability and pharmacokinetics.
- Phase 1 Study Designed to Evaluate the Safety, Tolerability and Pharmacokinetics of AT-587 in Healthy Volunteers AT-587 is a Potential First-in Class Treatment for Hepatitis E Virus, a Serious Liver Disease with No Approved Therapies Study Initiation Represents an Important Milestone Advancing Atea’s Antiviral Pipeline Focusing on First- or Best-in-Class Product Candidates in Areas of […]
- CHP investigates a case of human infection of rat Hepatitis E virusThe Centre for Health Protection
- CHP investigates a case of human infection of rat Hepatitis E virusThe Centre for Health Protection
- Discover how Hepatitis E viruses dynamically mutate during early acute infection, using transcomplementation to survive and adapt within the host.
- Knowing how viruses change in the initial weeks of an infection can provide important information about their adaptability. Researchers from the Ruhr University Bochum Departments of Molecular & Medical Virology and Translational & Computational Infection Research, Germany, have taken a closer look at the early phase of hepatitis E infections. To do this, they worked […]
- Knowing how viruses change in the initial weeks of an infection can provide important information about their adaptability.
- Knowing how viruses change in the initial weeks of an infection can provide important information about their adaptability. Researchers from the Departments of Molecular & Medical Virology and Translational …
- In immunocompromised patients the Hepatitis E Virus (HEV) can lead to severe liver injury and possible liver failure. This case report describes a patient wi…
- Find out what DAFM's landholding is in your county
- Hepatitis E virus genes have been identified in pigmeat products in several countries, including Ireland, according to the FSAI
- WHO fact sheet on hepatitis E, how it is transmitted, symptoms, prevention, testing and diagnosis, treatment and WHO activities.
- Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. This fact sheet provides information about transmission, symptoms, diagnosis, treatment, prevention and WHO's work to support prevention and treatment.

